Beneficial Cardiovascular Effects of Bariatric Surgical and Dietary Weight Loss in Obesity

Department of Cardiovascular Medicine, Oxford Centre for Clinical Magnetic Resonance Research, University of Oxford, Oxford, UK.
Journal of the American College of Cardiology (Impact Factor: 16.5). 09/2009; 54(8):718-26. DOI: 10.1016/j.jacc.2009.02.086
Source: PubMed


We hypothesized that, in obese persons without comorbidities, cardiovascular responses to excess weight are reversible during weight loss by either bariatric surgery or diet.
Obesity is associated with cardiac hypertrophy, diastolic dysfunction, and increased aortic stiffness, which are independent predictors of cardiovascular risk.
Thirty-seven obese (body mass index 40 +/- 8 kg/m(2)) and 20 normal-weight subjects (body mass index 21 +/- 2 kg/m(2)) without identifiable cardiac risk factors underwent cardiac magnetic resonance imaging for the assessment of the left and right ventricles and of indexes of aortic function. Thirty of the obese subjects underwent repeat imaging after 1 year of significant weight loss, achieved in 17 subjects by diet and in 13 subjects by bariatric surgery. Seven obese subjects underwent repeat imaging after 1 year of continued obesity.
Left and right ventricular masses were significantly increased, left ventricular diastolic function impaired, and aortic distensibility reduced in the obese. Both diet and bariatric surgery led to comparable, significant decreases in left and right ventricular masses, end-diastolic volume, and diastolic dysfunction, and an increase in aortic distensibility at all levels of the aorta, most pronounced distally (e.g., distal descending aorta 5.1 +/- 1.8 mm Hg(-1) x 10(-3) before weight loss and 6.8 +/- 2.5 mm Hg(-1) x 10(-3) after weight loss; p < 0.001). No improvements were observed in continued obesity.
Irrespective of method, 1 year of weight loss leads to partial regression of cardiac hypertrophy and to reversal of both diastolic dysfunction and aortic distensibility impairment. These findings provide a potential mechanism for the reduction in mortality seen with weight loss.

Download full-text


Available from: Oliver J Rider,
  • Source
    • "Interestingly, the effect of increasing BSA on aortic size seems to be most pronounced in the aortic root and ascending aorta, with a smaller effect seen distally. This pattern is the mirror image of increased aortic stiffness seen in obesity, which is more pronounced in the abdominal aorta than the ascending aorta [29], and may be explained by the proximal aorta being more directly exposed to the increased stroke volume accompanying larger fat mass and therefore showing the largest change in size, in line with its 'Windkessel’ function. In support of this, not only were aortic diameters positively correlated with left ventricular stroke volume, but also the largest effect was seen in the ascending aorta. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular magnetic resonance (CMR) is regarded as the gold standard for clinical assessment of the aorta, but normal dimensions are usually referenced to echocardiographic and computed tomography data and no large CMR normal reference range exists. As a result we aimed to 1) produce a normal CMR reference range of aortic diameters and 2) investigate the relationship between regional aortic size and body surface area (BSA) in a large group of healthy subjects with no vascular risk factors. 447 subjects (208 male, aged 19-70 years) without identifiable cardiac risk factors (BMI range 15.7-52.6 kg/m2) underwent CMR at 1.5 T to determine aortic diameter at three levels: the ascending aorta (Ao) and proximal descending aorta (PDA) at the level of the pulmonary artery, and the abdominal aorta (DDA), at a level 12 cm distal to the PDA. In addition, 201 of these subjects had aortic root imaging, allowing for measurements at the level of the aortic valve annulus (AV), aortic sinuses and sinotubular junction (STJ). Normal diameters (mean +/-2 SD) were; AV annulus male([male sign]) 24.4 +/- 5.4, female ([female sign]) 21.0 +/- 3.6 mm, aortic sinus[male sign]32.4 +/- 7.7, [female sign]27.6 +/- 5.8 mm, ST-junction [male sign]25.0 +/- 7.4, [female sign]21.8 +/- 5.4 mm, Ao [male sign]26.7 +/- 7.7, [female sign]25.5 +/- 7.4 mm, PDA [male sign]20.6 +/- 5.6, +18.9 +/- 4.0 mm, DDA [male sign]17.6 +/- 5.1, [female sign]16.4 +/- 4.0 mm. Aortic root and thoracic aortic diameters increased at all levels measured with BSA. No gender difference was seen in the degree of dilatation with increasing BSA (p > 0.5 for all analyses). Across both genders, increasing body size is characterized by a modest degree of aortic dilatation, even in the absence of traditional cardiovascular risk factors.
    Journal of Cardiovascular Magnetic Resonance 01/2014; 16(1):9. DOI:10.1186/1532-429X-16-9 · 4.56 Impact Factor
  • Source
    • "The clear effect of weight loss on reduction of LV mass has been more recently confirmed in series of obese patients undergone bariatric surgery [90] [91]. Although the reduction of LV mass observed with bariatric surgery is of similar magnitude as that obtained with sustained dietinduced weight loss [91], maintenance of a target body weight after surgery is easier than keeping patients on diet, though this advantage should be weighted by the potential complications and side-effect of surgical procedures in the long run. In contrast, aggressive antihypertensive treatment in hypertensive patients with LV hypertrophy was associated with impaired reduction in LV mass and less improvement in systolic LV function in obese compared to normal-weight subjects, despite comparable blood pressure reduction [86]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Obesity is characterized by the disproportionate growth of the components of body size, including adipose tissue and lean body mass. Left ventricular (LV) hypertrophy often develops, due to the coexistence of hemodynamic (cardiac workload) and non-hemodynamic components (including body composition and activity of visceral fat). While the hypertrophy of cardiomyocytes is produced by the hemodynamic load, through sarcomeric replication, there is a parallel growth of non-muscular myocardial components, including interstitial fat infiltration and accumulation of triglycerides in the contractile elements, which are thought to influence LV geometric pattern. Thus, pure intervention on hemodynamic load is unlikely to result in effective reduction of LV hypertrophy in obese. We review pathophysiology and prevalence of LV hypertrophy in obesity, with specific attention to LV geometric abnormalities and relations with body size.
    Nutrition, metabolism, and cardiovascular diseases: NMCD 10/2013; 23(10). DOI:10.1016/j.numecd.2013.06.012 · 3.32 Impact Factor
  • Source
    • "The association between obesity and LVM indicates that obesity can be used as a modifiable risk factor in the reduction of CVD mortality. Rider et al. [36] proved that weight loss leads to a reduction in LVM in obese non-CKD persons. Nonetheless, future studies are needed to confirm this effect in CKD patients. "
    [Show abstract] [Hide abstract]
    ABSTRACT: This study aimed to investigate the association of both body mass index (BMI) and waist circumference (WC) with left ventricular mass (LVM) in hypertensive predialysis chronic kidney disease (CKD) patients. From 2004 to 2005, 206 consecutive incident adult patients from the outpatient CKD clinics of two hospitals in Greece were included. Inclusion criteria were the presence of CKD and hypertension. BMI (kg/m(2)), WC (cm) and LVM (g) were assessed annually for 3 years. The mean age was 68.1 years, mean BMI 29.1 kg/m(2) and mean WC was 103.7 cm. The median LVM was 245.7 g (n = 179). In the cross-sectional data, linear regression models showed that WC {β = 1.2 [95% confidence interval (CI) 0.15; 2.3]}, and not BMI [β = 2.1 (95% CI: -0.70; 4.8)], was significantly associated with LVM. After adjustment for age, sex, primary renal disease, smoking and history of cardiovascular disease, both BMI [β = 4.7 (95% CI: 2.0; 7.4] and WC [β = 1.2 (95% CI: 0.14; 2.3)] were significantly associated with LVM. These associations were pronounced in CKD stage 1-3, but not in CKD stage 4-5. In the longitudinal analysis, linear mixed models adjusting for confounders showed that both an increase in BMI [β = 2.9 (95% CI: 0.74; 5.1)] and an increase in WC [β = 1.1 (95% CI: 0.28; 1.8)] were significantly associated with an increase in LVM. In hypertensive predialysis CKD patients, both BMI and WC were associated with LVM in CKD stage 1-3, but not in CKD stage 4-5. In the longitudinal analysis, both an increase in BMI and WC were associated with an increase in LVM. Future studies should focus on mechanisms responsible for the associations between anthropometric variables and LVM.
    Nephrology Dialysis Transplantation 09/2013; 28(Suppl 4). DOI:10.1093/ndt/gft356 · 3.58 Impact Factor
Show more